UK markets closed
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • FTSE 250

    19,123.71
    +430.73 (+2.30%)
     
  • AIM

    896.27
    +10.41 (+1.18%)
     
  • GBP/EUR

    1.1624
    -0.0022 (-0.19%)
     
  • GBP/USD

    1.2274
    +0.0013 (+0.11%)
     
  • BTC-GBP

    17,468.98
    +281.78 (+1.64%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • DOW

    31,500.68
    +823.32 (+2.68%)
     
  • CRUDE OIL

    107.06
    +2.79 (+2.68%)
     
  • GOLD FUTURES

    1,828.10
    -1.70 (-0.09%)
     
  • NIKKEI 225

    26,491.97
    +320.72 (+1.23%)
     
  • HANG SENG

    21,719.06
    +445.19 (+2.09%)
     
  • DAX

    13,118.13
    +205.54 (+1.59%)
     
  • CAC 40

    6,073.35
    +190.02 (+3.23%)
     

GlobalData Plc: COVID-19 Continues to Shape the Pharma Market

  • Oops!
    Something went wrong.
    Please try again later.
·5-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
GlobalData Plc
GlobalData Plc

COVID-19 driving key products and companies within the biopharmaceutical industry in 2022

LONDON, May 31, 2022 (GLOBE NEWSWIRE) -- Pfizer is forecast to continue to be the leading company by sales into 2022 due to its command of the COVID-19 market. Comirnaty, Pfizer’s COVID-19 vaccine, continues to have the highest sales going into 2022 despite a downward trend.

The Future of Pharma market research report offered by GlobalData Plc provides sales and regulatory-based insights into this coming year covering individual products and key areas of focus. The report gives regulatory-based insights into future trends that may negatively impact segments of the industry. It provides sales-based long-term insights into key sections of the industry and how they will change from this year (2022) to five years (2027) into the future and what is driving them. The report also offers clinical insights on planned and pivotal clinical trials based on this upcoming year and their trends.

Key Pharma Market Highlights

  • Oncology remains the leading therapy area despite significant growth in other therapy areas.

  • COVID-19 continues to dominate the key trends within the biopharmaceutical industry in 2022.

  • Phase IV trials are dominated by COVID-19 vaccines alongside psychedelic therapies.

  • Biologic drugs solidify their lead over small molecules and are now primary engines of value creation for large-cap pharma companies.

  • The majority of 2022 clinical trials are in late-stage development.

  • Eli Lilly is forecast to become a leading top 10 company within five years due to significant sales growth.

For more insights on the future of the pharmaceuticals market, download a free report sample

Pharma Market Segmentation by Therapy Area

  • Oncology

  • Infectious disease

  • Central nervous system

  • Immunology

  • Metabolic disorders

  • Cardiovascular

  • Respiratory

  • Hematological disorders

  • Ophthalmology

  • Gastrointestinal

Pharma Market Analysis, by Therapy Area

For more insights on key therapy areas, download a free report sample

Key Drugs in the Pharma Market

  • Keytruda

  • Opdivo

  • Revlimid

  • Comirnaty

  • Humira

  • Eliquis

  • Spikevax

  • Eylea

  • Stelara

  • Biktarvy

Pharma Market Analysis, by Drugs

For more insights on top drugs, download a free report sample

Leading Pharma Companies

  • Pfizer

  • Merck & Co

  • Novartis AG

  • Johnson & Johnson

  • Abbvie

  • F.Hoffman-La Roche Ltd

  • Bristol-Myers Squibb Co

  • AstraZeneca Plc

  • Sanofi

  • GlaxoSmithKline Plc

  • Novo Nordisk AS

  • Takeda Pharmaceutical Co Ltd

  • Novavax Inc

  • Bayer AG

  • Boehringer Ingelheim International GmbH

  • Eli Lilly and Co

Pharma Market Analysis, by Companies

To know more about leading companies, download a free report sample

Pharma Market Overview

Key Therapy Areas

Oncology, Infectious Disease, Central Nervous System, Immunology, Metabolic Disorders, Cardiovascular, Respiratory, Hematological Disorders, Ophthalmology, and Gastrointestinal

Key Drugs

Keytruda, Opdivo, Revlimid, Comirnaty, Humira, Eliquis, Spikevax, Eylea, Stelara, and Biktarvy

Leading Companies

Pfizer, Merck & Co, Novartis AG, Johnson & Johnson, Abbvie, F.Hoffman-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Sanofi, GlaxoSmithKline Plc, Novo Nordisk AS, Takeda Pharmaceutical Co Ltd, Novavax Inc, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Co

Pharma Market Report Scope

  • This 49-page report gives important, expert insight you won’t find in any other source. 21 figures throughout the report illustrate major points and trends in future pharmaceutical sales forecasts and company pipelines. This report is required reading for:

  • Investors that want to understand future trends impacting the biopharmaceutical industry as well as identify companies to invest in

  • Companies that are interested in entering the biopharmaceutical space and where best to focus on

  • Large pharma companies with investment groups or BD teams looking to see which companies are predicted to lead the industry in the near and far future

  • Small and medium pharma who want to focus their drug portfolio on future trends and are looking for partnership opportunities

Reasons to Buy

  • Year Ahead Opportunities – looking ahead in 2022 using sales and regulatory analyses to identify events and trends that may be opportunities.

  • Year Ahead Threats -looking ahead in 2022 using sales forecasts and clinical analyses to identify events and trends that may pose a threat.

  • Future opportunities – looking ahead 5 years into the future, using sales forecasts and analyses to identify the opportunities in 2027 that can be exploited.

  • Clinical trials – using clinical analyses to identify key areas within clinical trials that have begun or are planned for 2022.

FAQs

What are the key therapy areas in the pharma market?
Oncology, infectious disease, central nervous system, immunology, metabolic disorders, cardiovascular, respiratory, hematological disorders, ophthalmology, and gastrointestinal are the key therapy areas in the pharmaceuticals market.

What are the key drugs in the pharma market?
Keytruda, Opdivo, Revlimid, Comirnaty, Humira, Eliquis, Spikevax, Eylea, Stelara, and Biktarvy are the key drugs in the pharmaceuticals market.

Which are the leading companies in the pharma market?

Some of the leading pharmaceuticals companies are Pfizer, Merck & Co, Novartis AG, Johnson & Johnson, Abbvie, F.Hoffman-La Roche Ltd, Bristol-Myers Squibb Co, AstraZeneca Plc, Sanofi, GlaxoSmithKline Plc, Novo Nordisk AS, Takeda Pharmaceutical Co Ltd, Novavax Inc, Bayer AG, Boehringer Ingelheim International GmbH, Eli Lilly and Co

Related Reports

  • South Africa Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement, and Competitive Landscape – Click here

  • Chronic Kidney Disease Epidemiology Analysis and Forecast, 2021-2031 – Click here

  • Thailand Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement, and Competitive Landscape – Click here

  • Renal Cell Carcinoma Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media, and Competitive Landscape – Click here

  • Smoking Cessation Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape – Click here

About us

GlobalData is a leading provider of data, analytics, and insights on the world's largest industries. In an increasingly fast-moving, complex, and uncertain world, it has never been harder for organizations and decision makers to predict and navigate the future. This is why GlobalData's mission is to help our clients to decode the future and profit from faster, more informed decisions. As a leading information services company, thousands of clients rely on GlobalData for trusted, timely, and actionable intelligence. Our solutions are designed to provide a daily edge to professionals within corporations, financial institutions, professional services, and government agencies.

Media Contacts

GlobalData

Mark Jephcott
Head of PR EMEA
mark.jephcott@globaldata.com
cc: pr@globaldata.com

+44 (0)207 936 6400


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting